Exclusive to HMRI
Beyond Outputs: Attracting investment for research that advances innovation and maximises impact
- Want to know more about philanthropists and commercial investors decision making criteria to increase your success in securing funding?
- Want to know how to make your research more attractive to those seeking to fund commercialisation projects?
Dr Noel Chambers, CEO of NFMRI has generously agreed to visit HMRI to share his valuable insights into the art of securing vital funds for translational, innovative and collaborative health research.
As one of Australia’s leading non-government funding bodies in our sector and huge advocates for philanthropy to drive innovation in medical research, the NFMRI has a rich history of funding research that advances innovation and maximises impact. It is seen as one of the key players driving investment into the future of medical research.
Noel has had a unique career firstly as a researcher in pharmacology/medicinal chemistry at the University of Sydney. Followed by leading successful commercialisation, start-up companies, biotechnology projects and now in philanthropy.
In his current role he represents and collaborates with some of Australia’s leading philanthropists and is a champion for our sector to improve translational research outcomes whilst also holding relationships with philanthropic and venture capital investors to fund the development of commercialisation projects.
This event is for Health & Medical Researchers and their teams. It is open to HMRI Affiliates and other colleagues in the health and medical research sector who would like to attend.
Registration is vital to secure your place at this exclusive event.